173 related articles for article (PubMed ID: 35578218)
21. The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.
Strand TE; Rostad H; Strøm EH; Hasleton P
Diagn Pathol; 2015 Jul; 10():94. PubMed ID: 26159539
[TBL] [Abstract][Full Text] [Related]
22. Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma.
Sasada S; Nakayama H; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Murakami S; Ito H; Okada M
Ann Thorac Surg; 2015 Mar; 99(3):956-60. PubMed ID: 25620597
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.
Moon Y; Sung SW; Lee KY; Park JK
J Thorac Dis; 2016 Sep; 8(9):2562-2570. PubMed ID: 27747010
[TBL] [Abstract][Full Text] [Related]
24. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma.
Sasada S; Miyata Y; Mimae T; Mimura T; Okada M
Ann Thorac Surg; 2015 Dec; 100(6):2079-86. PubMed ID: 26298165
[TBL] [Abstract][Full Text] [Related]
25. Lepidic component at tumor margin: an independent prognostic factor in invasive lung adenocarcinoma.
Bian T; Jiang D; Feng J; Liu J; Qian L; Zhang Q; Li X; Liu Y; Zhang J
Hum Pathol; 2019 Jan; 83():106-114. PubMed ID: 30171990
[TBL] [Abstract][Full Text] [Related]
26. Differences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomas.
Katsumata S; Aokage K; Miyoshi T; Tane K; Nakamura H; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Hayashi R; Tsuboi M; Ishii G
J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1679-1688.e2. PubMed ID: 30257286
[TBL] [Abstract][Full Text] [Related]
27. Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma.
Weichert W; Warth A
Curr Opin Pulm Med; 2014 Jul; 20(4):309-16. PubMed ID: 24811831
[TBL] [Abstract][Full Text] [Related]
28. Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival.
Wang H; Schabath MB; Liu Y; Berglund AE; Bloom GC; Kim J; Stringfield O; Eikman EA; Klippenstein DL; Heine JJ; Eschrich SA; Ye Z; Gillies RJ
Clin Lung Cancer; 2015 Nov; 16(6):e141-63. PubMed ID: 26077095
[TBL] [Abstract][Full Text] [Related]
29. [New WHO classification of lung adenocarcinoma and preneoplasia].
Lantuejoul S; Rouquette I; Brambilla E; Travis WD
Ann Pathol; 2016 Jan; 36(1):5-14. PubMed ID: 26791238
[TBL] [Abstract][Full Text] [Related]
30. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
[TBL] [Abstract][Full Text] [Related]
31. A case of a rare non-invasive lung adenocarcinoma.
Yasukawa M; Itami H; Fujii T; Taniguchi S; Ohbayashi C
Int J Surg Case Rep; 2020; 76():386-389. PubMed ID: 33086165
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Factors of Non-Predominant-Lepidic Lung Adenocarcinoma Presenting as Ground Glass Opacity: Results of a Multicenter Study.
Messa F; Siciliani A; Piccioni G; Leonardi B; Ciccone AM; D'Andrilli A; Andreetti C; Menna C; Vanni C; Baccarini AE; Tiracorrendo M; Mancini M; Vecchione A; Nocera A; Calabrese G; Meacci E; Margaritora S; Natale G; Fiorelli A; Venuta F; Rendina EA; Maurizi G; Ibrahim M
J Pers Med; 2024 Jan; 14(2):. PubMed ID: 38392586
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2021 Jul; 12(14):2072-2077. PubMed ID: 34033216
[TBL] [Abstract][Full Text] [Related]
34. Differential gene expression profiles according to the Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society histopathological classification in lung adenocarcinoma subtypes.
Molina-Romero C; Rangel-Escareño C; Ortega-Gómez A; Alanis-Funes GJ; Avilés-Salas A; Avila-Moreno F; Mercado GE; Cardona AF; Hidalgo-Miranda A; Arrieta O
Hum Pathol; 2017 Aug; 66():188-199. PubMed ID: 28603066
[TBL] [Abstract][Full Text] [Related]
35. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.
Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938
[TBL] [Abstract][Full Text] [Related]
36. The difference in Ezrin-pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lung.
Hata K; Yoshida J; Udagawa H; Hashimoto H; Fujii S; Hishida T; Kuwata T; Aokage K; Kojima M; Ochiai A; Suzuki K; Tsuboi M; Ishii G
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1421-30. PubMed ID: 27059464
[TBL] [Abstract][Full Text] [Related]
37. Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Pääkkö P; Lappi-Blanco E; Kaarteenaho R
Histopathology; 2017 Sep; 71(3):425-436. PubMed ID: 28401582
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
[TBL] [Abstract][Full Text] [Related]
39. Correlation between Serum Carcinoembryonic Antigen Level and Histologic Subtype in Resected Lung Adenocarcinoma.
Tomita M; Ayabe T; Chosa E; Nakamura K
Asian Pac J Cancer Prev; 2015; 16(9):3857-60. PubMed ID: 25987049
[TBL] [Abstract][Full Text] [Related]
40. Adenocarcinoma classification: patterns and prognosis.
Kuhn E; Morbini P; Cancellieri A; Damiani S; Cavazza A; Comin CE
Pathologica; 2018 Mar; 110(1):5-11. PubMed ID: 30259909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
